Cargando…
Patient Understanding of the Neuropsychiatric Risks Associated with Branded Bupropion Hydrochloride Products Used for Smoking Cessation
BACKGROUND: Bupropion hydrochloride (Zyban) is an effective aid to smoking cessation; however, its use has previously been associated with neuropsychiatric adverse events. Here we report results of the patient Knowledge, Attitudes, and Behavior survey that forms part of the Year 7 Risk Evaluation an...
Autores principales: | Ascher, John, Stemhagen, Annette, Stender, Monika, Win, Beta, Winter, Christina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119167/ https://www.ncbi.nlm.nih.gov/pubmed/30105744 http://dx.doi.org/10.1007/s40801-018-0140-2 |
Ejemplares similares
-
The use of bupropion SR in cigarette smoking cessation
por: Wilkes, Scott
Publicado: (2008) -
Mania possibly linked with bupropion for smoking cessation: A case report
por: Dwyer, Stephanie, et al.
Publicado: (2016) -
Randomized trial of nicotine replacement therapy (NRT), bupropion and NRT plus bupropion for smoking cessation: effectiveness in clinical practice
por: Stapleton, John, et al.
Publicado: (2013) -
Assessment of the effectiveness of sustained release Bupropion and intensive physician advice in smoking cessation
por: Singh, Pranav, et al.
Publicado: (2010) -
Smoking Cessation Pharmacogenetics: Analysis of Varenicline and Bupropion in Placebo-Controlled Clinical Trials
por: King, David P, et al.
Publicado: (2012)